ITPD20020064A1 - Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem - Google Patents

Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem

Info

Publication number
ITPD20020064A1
ITPD20020064A1 IT2002PD000064A ITPD20020064A ITPD20020064A1 IT PD20020064 A1 ITPD20020064 A1 IT PD20020064A1 IT 2002PD000064 A IT2002PD000064 A IT 2002PD000064A IT PD20020064 A ITPD20020064 A IT PD20020064A IT PD20020064 A1 ITPD20020064 A1 IT PD20020064A1
Authority
IT
Italy
Prior art keywords
hyaluronic acid
biomedical
sanitary
hydrogeld
preparation
Prior art date
Application number
IT2002PD000064A
Other languages
English (en)
Inventor
Davide Bellini
Annamaria Zanellato
Original Assignee
Fidia Advanced Biopolymers Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Advanced Biopolymers Srl filed Critical Fidia Advanced Biopolymers Srl
Priority to IT2002PD000064A priority Critical patent/ITPD20020064A1/it
Priority to PCT/EP2003/002538 priority patent/WO2003076475A1/en
Priority to CA2478655A priority patent/CA2478655C/en
Priority to US10/507,472 priority patent/US7462606B2/en
Priority to AU2003227050A priority patent/AU2003227050B2/en
Priority to ES03743875T priority patent/ES2294305T3/es
Priority to EP03743875A priority patent/EP1519962B1/en
Priority to JP2003574690A priority patent/JP4458852B2/ja
Priority to DE60316291T priority patent/DE60316291T2/de
Priority to AT03743875T priority patent/ATE373018T1/de
Publication of ITPD20020064A1 publication Critical patent/ITPD20020064A1/it
Priority to US12/246,805 priority patent/US8178499B2/en
Priority to US12/246,970 priority patent/US8178663B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/04—Macromolecular materials
    • A61L29/043—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Transplantation (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Materials Engineering (AREA)
  • Ophthalmology & Optometry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
IT2002PD000064A 2002-03-12 2002-03-12 Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem ITPD20020064A1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT2002PD000064A ITPD20020064A1 (it) 2002-03-12 2002-03-12 Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem
ES03743875T ES2294305T3 (es) 2002-03-12 2003-03-12 Derivados ester del acido hialuronico para la preparacion de materiales de hidrogel mediante fotocurado.
CA2478655A CA2478655C (en) 2002-03-12 2003-03-12 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
US10/507,472 US7462606B2 (en) 2002-03-12 2003-03-12 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
AU2003227050A AU2003227050B2 (en) 2002-03-12 2003-03-12 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
PCT/EP2003/002538 WO2003076475A1 (en) 2002-03-12 2003-03-12 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
EP03743875A EP1519962B1 (en) 2002-03-12 2003-03-12 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
JP2003574690A JP4458852B2 (ja) 2002-03-12 2003-03-12 光硬化によるハイドロゲル材料の調製のためのヒアルロン酸のエステル誘導体
DE60316291T DE60316291T2 (de) 2002-03-12 2003-03-12 Esterderivate von hyaluronsäure zur herstellung von hydrogelmaterialien durch photohärtung
AT03743875T ATE373018T1 (de) 2002-03-12 2003-03-12 Esterderivate von hyaluronsäure zur herstellung von hydrogelmaterialien durch photohärtung
US12/246,805 US8178499B2 (en) 2002-03-12 2008-10-07 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
US12/246,970 US8178663B2 (en) 2002-03-12 2008-10-07 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002PD000064A ITPD20020064A1 (it) 2002-03-12 2002-03-12 Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem

Publications (1)

Publication Number Publication Date
ITPD20020064A1 true ITPD20020064A1 (it) 2003-09-12

Family

ID=27799887

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002PD000064A ITPD20020064A1 (it) 2002-03-12 2002-03-12 Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem

Country Status (10)

Country Link
US (3) US7462606B2 (it)
EP (1) EP1519962B1 (it)
JP (1) JP4458852B2 (it)
AT (1) ATE373018T1 (it)
AU (1) AU2003227050B2 (it)
CA (1) CA2478655C (it)
DE (1) DE60316291T2 (it)
ES (1) ES2294305T3 (it)
IT (1) ITPD20020064A1 (it)
WO (1) WO2003076475A1 (it)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20020064A1 (it) * 2002-03-12 2003-09-12 Fidia Advanced Biopolymers Srl Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem
US8137688B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US7465766B2 (en) 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US6982298B2 (en) 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8138265B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
ITPD20040053A1 (it) * 2004-02-27 2004-05-27 Fidia Advanced Biopolymers Srl Biomateriali costituiti da derivati dell'acido ialuronico come nuova terapia di cura per la protezione e la la riparazione della cartilagine articolare danneggiata per osteoartrosi
BRPI0515191A (pt) * 2004-08-13 2008-07-08 Angiotech Internac Ag composição farmacêutica, método para aumentar osso ou substituir perda óssea, método para reduzir a dor associada com cicatriz pós-cirúrgica, método para prevenir aderência cirúrgicas, método para aumento ou reparo de pele ou tecido, método para manter volume em fluido ocular durante cirurgia ocular, método para reduzir a dor associada com osteoartrite, método para tratar doença de refluxo gastroesofágico, método para tratar ou prevenir incontinência urinária, método para tratar ou prevenir incontinência fecal, implante método e dispositivo médico
US9205047B2 (en) * 2005-04-25 2015-12-08 The Governing Council Of The University Of Toronto Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix
US9205046B2 (en) * 2005-04-25 2015-12-08 The Governing Council Of The University Of Toronto Enhanced stability of inverse thermal gelling composite hydrogels
WO2007004675A1 (ja) 2005-07-06 2007-01-11 Seikagaku Corporation 薬剤導入光架橋ヒアルロン酸誘導体ゲル
CN101522133B (zh) * 2006-08-08 2012-08-08 伊纳斯米特基金会 可植入的光学系统，其开发和应用的方法
US8062364B1 (en) * 2007-04-27 2011-11-22 Knee Creations, Llc Osteoarthritis treatment and device
US9109051B2 (en) * 2007-12-19 2015-08-18 Evonik Goldschmidt Gmbh Crosslinked hyaluronic acid in emulsion
EP2249891B1 (en) 2008-02-13 2016-05-25 The Cleveland Clinic Foundation Molecular enhancement of extracellular matrix and methods of use
AU2009231634B2 (en) 2008-04-04 2014-05-15 University Of Utah Research Foundation Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
US8410180B2 (en) 2008-04-30 2013-04-02 The Cleveland Clinic Foundation Methods to treat urinary incontinence
CN101592772A (zh) * 2008-05-27 2009-12-02 鸿富锦精密工业（深圳）有限公司 镜头装置、用于收容该镜头装置的电子装置及摄像设备
WO2011063260A1 (en) * 2009-11-20 2011-05-26 Knee Creations, Llc Bone-derived implantable devices for subchondral treatment of joint pain
US8951261B2 (en) 2009-11-20 2015-02-10 Zimmer Knee Creations, Inc. Subchondral treatment of joint pain
KR20120112470A (ko) * 2009-11-20 2012-10-11 니 크리에이션스, 엘엘씨 관절 결함을 표적화하기 위한 기기
US8821504B2 (en) 2009-11-20 2014-09-02 Zimmer Knee Creations, Inc. Method for treating joint pain and associated instruments
KR20120132469A (ko) * 2009-11-20 2012-12-05 니 크리에이션스, 엘엘씨 관절 치료를 위한 좌표 맵핑 시스템
US8608802B2 (en) 2009-11-20 2013-12-17 Zimmer Knee Creations, Inc. Implantable devices for subchondral treatment of joint pain
US20110125264A1 (en) * 2009-11-20 2011-05-26 Knee Creations, Llc Implantable devices for subchondral treatment of joint pain
CN102740784B (zh) * 2009-11-20 2015-09-09 膝部创造物有限责任公司 用于对关节的可变角度进路的仪器
KR20120104580A (ko) 2009-11-20 2012-09-21 니 크리에이션스, 엘엘씨 관절 복원을 위한 내비게이션 및 위치결정 기기
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
JP2013188235A (ja) * 2010-06-28 2013-09-26 Terumo Corp 人工弁
AU2012220633A1 (en) 2011-02-22 2013-08-29 Jamie A. CARROLL Navigation and positioning systems and guide instruments for joint repair
CA2830933A1 (en) 2011-03-23 2012-09-27 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
CN103841927A (zh) 2011-06-09 2014-06-04 齐默尔膝部创造物公司 用于软骨下关节修复的器械和装置
US20120316571A1 (en) 2011-06-10 2012-12-13 Knee Creations, Llc Subchondral treatment of osteoarthritis in joints
US9138187B2 (en) 2011-08-07 2015-09-22 Zimmer Knee Creations, Inc. Treatment of subchondral bone by biochemical diagnosis to prevent the progression of osteoarthritis of the joint
US9119646B2 (en) 2011-08-07 2015-09-01 Zimmer Knee Creations, Inc. Subchondral treatment to prevent the progression of osteoarthritis of the joint
US8623089B2 (en) 2011-08-07 2014-01-07 Zimmer Knee Creations, Inc. Subchondral treatment of joint pain of the spine
WO2013055891A1 (en) 2011-10-11 2013-04-18 Knee Creations Llc. Methods and instruments for subchondral treatment of osteoarthritis in a small joint
WO2013149256A2 (en) 2012-03-30 2013-10-03 Zimmer Gmbh, Inc. Surgical access systems, instruments and accessories
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
EP2892458B1 (en) 2012-09-07 2019-08-14 Zimmer Knee Creations, Inc. Instruments for controlled delivery of injectable materials into bone
WO2014053913A2 (en) 2012-09-07 2014-04-10 Zimmer Knee Creations, Inc. Navigation instruments for subchondral bone treatment
WO2014039995A1 (en) 2012-09-07 2014-03-13 Fibrocell Technologies, Inc. Fibroblast compositions for treating cardial damage after an infarct
CZ2012842A3 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
ITMI20130162A1 (it) * 2013-02-06 2014-08-07 Fidia Farmaceutici Derivati fotoreticolati di acido ialuronico, loro processo di preparazione ed impiego
AU2013205148B2 (en) 2013-03-14 2014-10-30 AVITA Medical Americas, LLC Systems and methods for tissue processing and preparation of cell suspension therefrom
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
CZ304977B6 (cs) 2013-11-21 2015-02-25 Contipro Biotech S.R.O. Nanovlákna obsahující fototvrditelný esterový derivát kyseliny hyaluronové nebo její soli, fototvrzená nanovlákna, způsob jejich syntézy, přípravek obsahující fototvrzená nanovlákna a jejich použití
CZ305153B6 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
CZ306479B6 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
WO2017100927A1 (en) 2015-12-15 2017-06-22 Neovasc Tiara Inc. Transseptal delivery system
JP7006940B2 (ja) 2016-01-29 2022-01-24 ニオバスク ティアラ インコーポレイテッド 流出の閉塞を回避するための人工弁
CA3021764C (en) 2016-04-27 2021-01-19 Anika Therapeutics, Inc. Compositions for use in treating tendon degeneration via intra-osteotendinous injection
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
AU2017204355B2 (en) 2016-07-08 2021-09-09 Mako Surgical Corp. Scaffold for alloprosthetic composite implant
US11337994B2 (en) 2016-09-15 2022-05-24 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
WO2018090148A1 (en) 2016-11-21 2018-05-24 Neovasc Tiara Inc. Methods and systems for rapid retraction of a transcatheter heart valve delivery system
AR111190A1 (es) 2017-03-22 2019-06-12 Genentech Inc Composiciones en hidrogel de prodrogas entrecruzadas de ácido hialurónico y métodos relacionados
WO2019028248A1 (en) * 2017-08-02 2019-02-07 Young Pharmaceuticals, Inc. SYSTEMS AND METHODS FOR IMPROVING THE ADMINISTRATION OF TOPICAL ACTIVE AGENTS
CN111263622A (zh) 2017-08-25 2020-06-09 内奥瓦斯克迪亚拉公司 顺序展开的经导管二尖瓣假体
AU2019374743B2 (en) 2018-11-08 2022-03-03 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
CN111228653A (zh) 2018-11-13 2020-06-05 格莱科米拉治疗公司 用电离辐射加强癌症治疗的方法
JP7430732B2 (ja) 2019-03-08 2024-02-13 ニオバスク ティアラ インコーポレイテッド 回収可能補綴物送達システム
EP3946163B1 (en) 2019-04-01 2025-08-20 Neovasc Tiara Inc. Controllably deployable prosthetic valve
US11491006B2 (en) 2019-04-10 2022-11-08 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
EP4729110A2 (en) 2019-05-20 2026-04-22 Neovasc Tiara Inc. Introducer with hemostasis mechanism
WO2020257643A1 (en) 2019-06-20 2020-12-24 Neovasc Tiara Inc. Low profile prosthetic mitral valve
US12570949B2 (en) 2022-12-27 2026-03-10 AVITA Medical Americas, LLC Systems and devices for wound therapy and related methods of use
DE202023002794U1 (de) 2022-12-27 2024-07-15 AVITA Medical Americas, LLC Kassette zur Herstellung einer regenerativen epidermalen Suspension
USD1112812S1 (en) 2023-12-22 2026-02-10 AVITA Medical Americas, LLC Tissue processing cartridge

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2553099B1 (fr) 1983-10-11 1989-09-08 Fidia Spa Fractions d'acide hyaluronique ayant une activite pharmaceutique, procedes pour leur preparation et compositions pharmaceutiques les contenant
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5410016A (en) 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5529914A (en) 1990-10-15 1996-06-25 The Board Of Regents The Univeristy Of Texas System Gels for encapsulation of biological materials
JP2855307B2 (ja) 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
IT1263393B (it) 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Processo per la preparazione e purificazione di acido ialuronico ad alto peso molecolare
IT1268954B1 (it) 1994-03-11 1997-03-18 Fidia Advanced Biopolymers Srl Processo per la preparazione di acido ialuronico mediante sintesienzimatica e relative composizioni farmaceutiche
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
PL182804B1 (pl) 1995-02-07 2002-03-29 Fidia Advanced Biopolymers Sposób powlekania powierzchni przedmiotu kwasem hialuronowym lub pochodną kwasu hialuronowego i sposób powlekania powierzchni przedmiotu polimerem półsyntetycznym
IT1281886B1 (it) * 1995-05-22 1998-03-03 Fidia Advanced Biopolymers Srl Processo per la preparazione di idrogel ottenuti da derivati chimici dell'acido ialuronico mediante irradiazioni ultraviolette e loro
US5612321A (en) 1995-06-22 1997-03-18 Hercules Incorporated Antioxidant grafted polysaccharides
ATE221086T1 (de) * 1995-11-15 2002-08-15 Seikagaku Kogyo Co Ltd Photovernetztes hyaluronsäuregel und verfahren zu dessen herstellung
DK0971961T3 (da) 1997-04-04 2003-03-24 Fidia Advanced Biopolymers Srl N-sulfaterede hyaluronsyreforbindelser, derivater deraf og en fremgangsmåde til deres fremstilling
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
US6630457B1 (en) 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
ITPD20020064A1 (it) * 2002-03-12 2003-09-12 Fidia Advanced Biopolymers Srl Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem

Also Published As

Publication number Publication date
US7462606B2 (en) 2008-12-09
DE60316291D1 (de) 2007-10-25
JP2005535736A (ja) 2005-11-24
US20090075911A1 (en) 2009-03-19
WO2003076475A1 (en) 2003-09-18
US20050119219A1 (en) 2005-06-02
ATE373018T1 (de) 2007-09-15
ES2294305T3 (es) 2008-04-01
AU2003227050B2 (en) 2008-11-06
CA2478655C (en) 2012-05-08
CA2478655A1 (en) 2003-09-18
AU2003227050A1 (en) 2003-09-22
US20090076257A1 (en) 2009-03-19
EP1519962B1 (en) 2007-09-12
DE60316291T2 (de) 2008-06-05
JP4458852B2 (ja) 2010-04-28
EP1519962A1 (en) 2005-04-06
US8178499B2 (en) 2012-05-15
US8178663B2 (en) 2012-05-15

Similar Documents

Publication Publication Date Title
ITPD20020064A1 (it) Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem
Abatangelo et al. Hyaluronic acid: redefining its role
Zhu et al. Tazarotene released from aligned electrospun membrane facilitates cutaneous wound healing by promoting angiogenesis
de Sousa Victor et al. A review on Chitosan’s uses as biomaterial: Tissue engineering, drug delivery systems and cancer treatment
Chen et al. Structure and properties of gelatin methacryloyl (GelMA) synthesized in different reaction systems
Shen et al. Advances in functional hydrogel wound dressings: a review
Hama et al. Recent developments in biopolymer-based hydrogels for tissue engineering applications
Valachová et al. Hyaluronan as a prominent biomolecule with numerous applications in medicine
Ezhilarasu et al. Biocompatible aloe vera and tetracycline hydrochloride loaded hybrid nanofibrous scaffolds for skin tissue engineering
Lyu et al. Application of silk-fibroin-based hydrogels in tissue engineering
Wang et al. Ultrashort peptides and hyaluronic acid-based injectable composite hydrogels for sustained drug release and chronic diabetic wound healing
Sugiaman et al. Polymeric scaffolds used in dental pulp regeneration by tissue engineering approach
Cui et al. Poloxamer-based scaffolds for tissue engineering applications: a review
Cadinoiu et al. Silver nanoparticles biocomposite films with antimicrobial activity: In vitro and in vivo tests
Varma et al. Biopolymers and their role in medicinal and pharmaceutical applications
Perez-Araluce et al. Biomaterials-based antioxidant strategies for the treatment of oxidative stress diseases
DE69516960D1 (de) Sulfatierte hyaluronsäure mit 0.5 bis weniger als 2 sulfate gruppen pro einheit
PT1144459E (pt) Acidos hialuronicos reticulados e as suas utilizacoes em medicina
Smagina et al. Polymeric gel systems cytotoxicity and drug release as key features for their effective application in various fields of addressed pharmaceuticals delivery
SMT201300095B (it) Uso dell'estere etilico dell'acido eicosapentaenoico per trattare l'ipertrigliceridemia
ES2181608T1 (es) Procedimiento para la produccion de derivaods de acido hialuronico reticulados de forma multiple.
Hwang et al. Electrospun nanofiber composite mat based on ulvan for wound dressing applications
Lin et al. Photocrosslinked gelatin methacryloyl (GelMA)/hyaluronic acid methacryloyl (HAMA) composite scaffold using anthocyanidin as a photoinitiator for bone tissue regeneration
ITTO20121107A1 (it) Composizione a base di polidesossiribonucleotidi e relativi usi
Hejran et al. The importance of hyaluronic acid in biological systems